Literature DB >> 18588283

Data mining the NCI60 to predict generalized cytotoxicity.

Adam C Lee1, Kerby Shedden, Gustavo R Rosania, Gordon M Crippen.   

Abstract

Elimination of cytotoxic compounds in the early and later stages of drug discovery can help reduce the costs of research and development. Through the application of principal components analysis (PCA), we were able to data mine and prove that approximately 89% of the total log GI 50 variance is due to the nonspecific cytotoxic nature of substances. Furthermore, PCA led to the identification of groups of structurally unrelated substances showing very specific toxicity profiles, such as a set of 45 substances toxic only to the Leukemia_SR cancer cell line. In an effort to predict nonspecific cytotoxicity on the basis of the mean log GI 50, we created a decision tree using MACCS keys that can correctly classify over 83% of the substances as cytotoxic/noncytotoxic in silico, on the basis of the cutoff of mean log GI 50 = -5.0. Finally, we have established a linear model using least-squares in which nine of the 59 available NCI60 cancer cell lines can be used to predict the mean log GI 50. The model has R (2) = 0.99 and a root-mean-square deviation between the observed and calculated mean log GI 50 (RMSE) = 0.09. Our predictive models can be applied to flag generally cytotoxic molecules in virtual and real chemical libraries, thus saving time and effort.

Entities:  

Mesh:

Year:  2008        PMID: 18588283      PMCID: PMC2561991          DOI: 10.1021/ci800097k

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  13 in total

Review 1.  ADMET in silico modelling: towards prediction paradise?

Authors:  Han van de Waterbeemd; Eric Gifford
Journal:  Nat Rev Drug Discov       Date:  2003-03       Impact factor: 84.694

Review 2.  Integration of virtual and high-throughput screening.

Authors:  Jürgen Bajorath
Journal:  Nat Rev Drug Discov       Date:  2002-11       Impact factor: 84.694

3.  NIH Molecular Libraries Initiative.

Authors:  Christopher P Austin; Linda S Brady; Thomas R Insel; Francis S Collins
Journal:  Science       Date:  2004-11-12       Impact factor: 47.728

Review 4.  Chemical structure indexing of toxicity data on the internet: moving toward a flat world.

Authors:  Ann M Richard; Lois Swirsky Gold; Marc C Nicklaus
Journal:  Curr Opin Drug Discov Devel       Date:  2006-05

5.  Assessment of in vitro and in vivo activities in the National Cancer Institute's anticancer screen with respect to chemical structure, target specificity, and mechanism of action.

Authors:  Ruili Huang; Anders Wallqvist; David G Covell
Journal:  J Med Chem       Date:  2006-03-23       Impact factor: 7.446

6.  Flexible Web service infrastructure for the development and deployment of predictive models.

Authors:  Rajarshi Guha
Journal:  J Chem Inf Model       Date:  2008-01-25       Impact factor: 4.956

7.  Predicting cancer drug response by proteomic profiling.

Authors:  Yan Ma; Zhenyu Ding; Yong Qian; Xianglin Shi; Vince Castranova; E James Harner; Lan Guo
Journal:  Clin Cancer Res       Date:  2006-08-01       Impact factor: 12.531

8.  COMPARE: a web accessible tool for investigating mechanisms of cell growth inhibition.

Authors:  Daniel W Zaharevitz; Susan L Holbeck; Christopher Bowerman; Penny A Svetlik
Journal:  J Mol Graph Model       Date:  2002-01       Impact factor: 2.518

9.  Life cycle of a block buster drug: discovery and development of omeprazole (Prilosec).

Authors:  Barry A Berkowitz; George Sachs
Journal:  Mol Interv       Date:  2002-02

Review 10.  Screening of toxic compounds in mammalian cell cultures.

Authors:  B Ekwall
Journal:  Ann N Y Acad Sci       Date:  1983       Impact factor: 5.691

View more
  17 in total

1.  The slow cell death response when screening chemotherapeutic agents.

Authors:  Joseph Blois; Adam Smith; Lee Josephson
Journal:  Cancer Chemother Pharmacol       Date:  2010-12-31       Impact factor: 3.333

2.  Naïve Bayesian Models for Vero Cell Cytotoxicity.

Authors:  Alexander L Perryman; Jimmy S Patel; Riccardo Russo; Eric Singleton; Nancy Connell; Sean Ekins; Joel S Freundlich
Journal:  Pharm Res       Date:  2018-06-29       Impact factor: 4.200

3.  Modelling compound cytotoxicity using conformal prediction and PubChem HTS data.

Authors:  Fredrik Svensson; Ulf Norinder; Andreas Bender
Journal:  Toxicol Res (Camb)       Date:  2016-10-31       Impact factor: 3.524

4.  Gene expression associations with the growth inhibitory effects of small molecules on live cells: specificity of effects and uniformity of mechanisms.

Authors:  Kerby Shedden; Yang Yang; Gus Rosania
Journal:  Stat Anal Data Min       Date:  2009-09-01       Impact factor: 1.051

5.  Comparing Multiple Machine Learning Algorithms and Metrics for Estrogen Receptor Binding Prediction.

Authors:  Daniel P Russo; Kimberley M Zorn; Alex M Clark; Hao Zhu; Sean Ekins
Journal:  Mol Pharm       Date:  2018-08-28       Impact factor: 4.939

6.  Investigating the correlations among the chemical structures, bioactivity profiles and molecular targets of small molecules.

Authors:  Tiejun Cheng; Yanli Wang; Stephen H Bryant
Journal:  Bioinformatics       Date:  2010-10-13       Impact factor: 6.937

Review 7.  Genomics: applications in mechanism elucidation.

Authors:  Venita Gresham; Howard L McLeod
Journal:  Adv Drug Deliv Rev       Date:  2008-12-31       Impact factor: 15.470

8.  Chemical address tags of fluorescent bioimaging probes.

Authors:  Kerby Shedden; Gus R Rosania
Journal:  Cytometry A       Date:  2010-05       Impact factor: 4.355

9.  Integrating constitutive gene expression and chemoactivity: mining the NCI60 anticancer screen.

Authors:  David G Covell
Journal:  PLoS One       Date:  2012-10-02       Impact factor: 3.240

10.  Predicting cytotoxicity from heterogeneous data sources with Bayesian learning.

Authors:  Sarah R Langdon; Joanna Mulgrew; Gaia V Paolini; Willem P van Hoorn
Journal:  J Cheminform       Date:  2010-12-09       Impact factor: 5.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.